- Report
- January 2023
- 95 Pages
Global
From €2407EUR$2,490USD£2,068GBP
- Report
- January 2023
- 125 Pages
Global
From €2407EUR$2,490USD£2,068GBP
- Report
- April 2024
- 185 Pages
From €4737EUR$4,900USD£4,069GBP
- Report
- November 2023
- 77 Pages
India
From €3384EUR$3,500USD£2,906GBP
- Report
- August 2021
- 80 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- August 2022
- 115 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- July 2022
- 112 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- January 2023
- 220 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- December 2022
- 122 Pages
North America
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- December 2022
- 137 Pages
Europe
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- September 2022
- 202 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- August 2022
- 273 Pages
Europe
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- May 2022
- 347 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- May 2022
- 152 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- September 2020
- 129 Pages
North America
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- September 2020
- 130 Pages
Asia Pacific
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- September 2020
- 118 Pages
North America
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- April 2021
- 100 Pages
Global
From €4636EUR$4,795USD£3,982GBP
- Report
- April 2021
- 121 Pages
Global
From €10630EUR$10,995USD£9,130GBP
- Report
- November 2020
- 121 Pages
Global
From €10630EUR$10,995USD£9,130GBP
The Lung Disease market within the context of Pulmonary Medicine is a highly specialized field of medicine that focuses on the diagnosis and treatment of diseases and disorders of the lungs. This includes conditions such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary hypertension, and lung cancer. Pulmonologists are the primary healthcare providers for these conditions, and they work closely with other specialists such as allergists, oncologists, and radiologists to provide comprehensive care.
The Lung Disease market is a rapidly growing field, with new treatments and technologies being developed to improve patient outcomes. In addition, the increasing prevalence of smoking and air pollution has led to an increase in the number of people suffering from lung diseases.
Some of the major companies in the Lung Disease market include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are involved in the development and marketing of drugs, devices, and diagnostics for the treatment of lung diseases. Show Less Read more